Bradway Robert A
SEC CIK 1396482 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | COB, CEO, Pres, Dir | 505.2K | — | — | 33 | 2022-03-01 | 2026-05-07 |
Most active insiders at AMGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Santos Esteban | EVP, Ops | — | $20.77M |
| 2 | Grygiel Nancy A. | SVP, CCO | — | $2.65M |
| 3 | Gordon Murdo | EVP, Gbl Commercial Ops | — | $2.32M |
| 4 | Khosla Rachna | SVP, Business Development | — | $1.65M |
| 5 | Miller Derek | SVP, Human Resources | — | $1.57M |
| 6 | Busch Matthew C. | VP, CAO, Fin | — | $375.8K |
| 7 | Klotman Mary E. | Dir | — | — |
| 8 | Bradner James E. | EVP, Research, Development | — | — |
| 9 | Drake Michael V | Dir | — | — |
| 10 | Griffith Peter H. | EVP, CFO | — | — |
| 17 | Bradway Robert A | COB, CEO, Pres, Dir | — | — |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 19:39 | 2026-05-07 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $331.11 | -2,079 | 505.2K | -0.4% | -$688.4K | |
| D | 2026-05-07 21:12 | 2026-05-05 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | A - Grant | $0.00 | +12.1K | 508.9K | +2% | $0 |
| D | 2026-05-07 21:12 | 2026-05-06 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $329.59 | -1,702 | 507.2K | -0.3% | -$561.0K |
| M | 2026-05-05 19:52 | 2026-05-02 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $329.82 | -5,057 | 496.8K | -1% | -$1.67M |
| 2026-03-18 | 2026-03-16 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $366.21 | -21.3K | 501.9K | -4% | -$7.80M | |
| D | 2026-03-06 | 2026-03-04 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | M - OptEx | $156.35 | +119.8K | 576.9K | +26% | +$18.73M |
| D | 2026-03-06 | 2026-03-04 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $379.27 | -84.3K | 492.6K | -15% | -$31.97M |
| 2026-03-05 | 2026-03-03 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | A - Grant | $0.00 | +42.7K | 457.1K | +10% | $0 | |
| D | 2025-05-08 | 2025-05-06 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | A - Grant | $0.00 | +13.3K | 413.5K | +3% | $0 |
| M | 2025-05-06 | 2025-05-02 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $283.78 | -4,833 | 402.5K | -1% | -$1.37M |
| 2025-05-02 | 2025-04-30 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $288.56 | -2,544 | 405.0K | -0.6% | -$734.1K | |
| 2025-03-19 | 2025-03-17 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $313.71 | -12.9K | 587.6K | -2% | -$4.03M | |
| 2025-03-05 | 2025-03-03 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | A - Grant | $0.00 | +25.7K | 599.9K | +4% | $0 | |
| I | 2024-12-03 | 2024-12-02 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | G - Gift | $0.00 | +90.0K | 90.0K | New | $0 |
| M | 2024-12-03 | 2024-12-02 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | G - Gift | $0.00 | -186.0K | 573.9K | -24% | $0 |
| D | 2024-05-09 | 2024-05-07 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | A - Grant | $0.00 | +12.0K | 669.3K | +2% | $0 |
| 2024-05-07 | 2024-05-05 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $311.29 | -2,220 | 657.3K | -0.3% | -$691.1K | |
| 2024-05-06 | 2024-05-02 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $277.37 | -2,294 | 659.5K | -0.3% | -$636.3K | |
| 2024-05-01 | 2024-04-30 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $276.38 | -2,282 | 661.8K | -0.3% | -$630.7K | |
| 2024-03-20 | 2024-03-18 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $268.87 | -20.6K | 664.1K | -3% | -$5.53M | |
| 2024-03-08 | 2024-03-06 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | A - Grant | $0.00 | +41.1K | 683.9K | +6% | $0 | |
| 2023-05-09 | 2023-05-05 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $231.89 | -2,083 | 641.7K | -0.3% | -$483.0K | |
| D | 2023-05-04 | 2023-05-03 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $235.97 | -2,863 | 643.8K | -0.4% | -$675.6K |
| D | 2023-05-04 | 2023-05-02 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | A - Grant | $0.00 | +13.5K | 646.7K | +2% | $0 |
| 2023-05-02 | 2023-04-30 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $239.74 | -2,208 | 633.2K | -0.3% | -$529.3K | |
| 2023-03-20 | 2023-03-17 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $234.57 | -14.0K | 635.4K | -2% | -$3.28M | |
| 2023-03-08 | 2023-03-06 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | A - Grant | $0.00 | +27.9K | 648.7K | +4% | $0 | |
| 2022-05-09 | 2022-05-05 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $236.10 | -2,017 | 619.8K | -0.3% | -$476.2K | |
| D | 2022-05-04 | 2022-05-03 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $230.92 | -2,692 | 621.9K | -0.4% | -$621.6K |
| D | 2022-05-04 | 2022-05-02 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | A - Grant | $0.00 | +13.8K | 624.5K | +2% | $0 |
| 2022-04-29 | 2022-04-27 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $249.87 | -2,547 | 610.8K | -0.4% | -$636.4K | |
| 2022-03-22 | 2022-03-18 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | F - Tax | $235.86 | -17.5K | 613.3K | -3% | -$4.12M | |
| 2022-03-03 | 2022-03-01 | AMGN | Amgen | Bradway Robert A | COB, CEO, Pres, Dir | A - Grant | $0.00 | +35.0K | 630.1K | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations